Phenotype-Led Identification of IL-10 Upregulators in Human CD4 + T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 Inhibitors
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c02630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Simon Nicolle und 21 weiteren Autor:innen. Beteiligte Einrichtung: Medicine Design, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 8, CD4-Positive T-Lymphocytes, Interleukin-10, Cyclin-Dependent Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Therapeutics promoting the endogenous production of IL-10 have the potential to restore homeostasis in inflammatory disorders such as inflammatory bowel disease (IBD). Here we describe the identification of a series of IL-10 upregulators based on a pyrimidyl-piperidine scaffold through a high throughput phenotypic CD4+ T-cell multiplex assay. In vitro optimization of the initial hit yielded a lead with good potency and an in vitro clearance profile, compound 3-7, which additionally demonstrated efficacy in a murine endotoxin challenge PK-PD mechanistic model. Target deconvolution efforts identified compound 3-7 as a highly selective CDK8/19 inhibitor, and crystallographic studies unveiled its binding mode to the CDK8/Cyclin-C complex, characterized by an unusual water-mediated hydrogen bond to the kinase hinge region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medicine Design, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
- In Vitro In Vivo Translation, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
- Medicine Development and Supply, GlaxoSmithKline R&D Hub, 1250 South Collegeville Road, Upper Providence, Pennsylvania 19426, United States.
- Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg 69117, Germany.
- Immunology Research Unit GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
ORCID-Profile: Simon Nicolle, Stephen J Atkinson, Helen Aylott, Nico Zinn
Zitieren
APA
Nicolle, S., Barker, M., Barrett, J., Campbell, M., Wojno-Picon, J., Atkinson, S. J., Aylott, H., Kessedjian, H., He, Y., Messenger, C., Roberts, E., Spitzfaden, C., Le, J., Zinn, N., Werner, T., Dümpelfeld, B., Bantscheff, M., Somers, D. O., Reid, H., …, & Lewis, H. D. (2025). Phenotype-Led Identification of IL-10 Upregulators in Human CD4 + T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 Inhibitors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02630
Vancouver
Nicolle S, Barker M, Barrett J, Campbell M, Wojno-Picon J, Atkinson SJ, et al. Phenotype-Led Identification of IL-10 Upregulators in Human CD4 + T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 Inhibitors. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02630
BibTeX
@article{Nicolle2025,
author = {Nicolle, Simon and Barker, Mike and Barrett, John and Campbell, Matthew and Wojno-Picon, Justyna and Atkinson, Stephen J and Aylott, Helen and Kessedjian, Hripsimee and He, Yanan and Messenger, Cassie and Roberts, Emma and Spitzfaden, Claus and Le, Joelle and Zinn, Nico and Werner, Thilo and Dümpelfeld, Birgit and Bantscheff, Marcus and Somers, Don O and Reid, Heather and Thang, Kevin and Gobbetti, Thomas and Lewis, Huw D},
title = {Phenotype-Led Identification of IL-10 Upregulators in Human CD4 + T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c02630}
}
EUVIMED